Modeling Human Muscular Dystrophies in Zebrafish: Mutant Lines, Transgenic Fluorescent Biosensors, and Phenotyping Assays

Abstract

Muscular dystrophies (MDs) are a heterogeneous group of myopathies characterized by progressive muscle weakness leading to death from heart or respiratory failure. MDs are caused by mutations in genes involved in both the development and organization of muscle fibers. Several animal models harboring mutations in MD-associated genes have been developed so far. Together with rodents, the zebrafish is one of the most popular animal models used to reproduce MDs because of the high level of sequence homology with the human genome and its genetic manipulability. This review describes the most important zebrafish mutant models of MD and the most advanced tools used to generate and characterize all these valuable transgenic lines. Zebrafish models of MDs have been generated by introducing mutations to muscle-specific genes with different genetic techniques, such as (i) N-ethyl-N-nitrosourea (ENU) treatment, (ii) the injection of specific morpholino, (iii) tol2-based transgenesis, (iv) TALEN, (v) and CRISPR/Cas9 technology. All these models are extensively used either to study muscle development and function or understand the pathogenetic mechanisms of MDs. Several tools have also been developed to characterize these zebrafish models by checking (i) motor behavior, (ii) muscle fiber structure, (iii) oxidative stress, and (iv) mitochondrial function and dynamics. Further, living biosensor models, based on the expression of fluorescent reporter proteins under the control of muscle-specific promoters or responsive elements, have been revealed to be powerful tools to follow molecular dynamics at the level of a single muscle fiber. Thus, zebrafish models of MDs can also be a powerful tool to search for new drugs or gene therapies able to block or slow down disease progression.

Modeling Sarcoglycanopathy in Danio rerio

“…In this latter case, the SG-KO lines could be crossed with transgenic zebrafish lines expressing the genetic probes targeted to different organelles and/or expressed in a tissue specific manner [ 84 , 85 ]. This will also be possible thanks to the external development of the organism, the large numbers of individuals at each mating, and the transparency of the embryos and larvae, which allows for direct visualization of the development of tissues and organs such as the muscle and the heart [ 36 ].…”

Standardization of zebrafish drug testing parameters for muscle diseases

“…Histological and immunological markers are often studied in zebrafish-based drug screening and basic molecular mechanistic studies. Many different muscle and NMD-related cell types express markers that can be used for labeling, and there are several transgenic zebrafish reporter lines with labelled skeletal muscle-related cells and tissues ( Tesoriero et al, 2023 ). Here, we focus on some of the most commonly used markers ( Table 3 ).…”

Zebrafish as a robust preclinical platform for screening plant-derived drugs with anticonvulsant properties—a review

“…Zebrafish ( Danio rerio ) is a small striped minnow natural to the freshwaters of the Indian subcontinent. Since their first scientific use in the 1960s, the popularity of zebrafish in biomedical sciences has been increasing at a rapid pace ( Stewart et al, 2014 ; Crouzier et al, 2021 ; Al-Hamaly et al, 2023 ; Chang et al, 2023 ; Liu, 2023 ; Tesoriero et al, 2023 ). Zebrafish is a very popular organism for high-throughput screening studies ( Baxendale et al, 2012 ; Baraban et al, 2013 ; Asad et al, 2023 ).…”